152 related articles for article (PubMed ID: 30002362)
81. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis.
Kokkola R; Sundberg E; Ulfgren AK; Palmblad K; Li J; Wang H; Ulloa L; Yang H; Yan XJ; Furie R; Chiorazzi N; Tracey KJ; Andersson U; Harris HE
Arthritis Rheum; 2002 Oct; 46(10):2598-603. PubMed ID: 12384917
[TBL] [Abstract][Full Text] [Related]
82. Can effluent hyaluronic acid or creatine kinase predict sinusoidal injury severity after cold ischemia?
Karayalçin K; Harrison JD; Attard A; Gunson BK; Jones S; Mayer D; Buckels JA; McMaster P
Transplantation; 1993 Dec; 56(6):1336-9. PubMed ID: 8278999
[TBL] [Abstract][Full Text] [Related]
83. Defining long-term outcomes with living donor liver transplantation in North America.
Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
[TBL] [Abstract][Full Text] [Related]
84. Prediction of Graft Survival Post-liver Transplantation by L-GrAFT Risk Score Model, EASE Score, MEAF Scoring, and EAD.
Chen S; Wang T; Luo T; He S; Huang C; Jia Z; Zhan L; Wang D; Zhu X; Guo Z; He X
Front Surg; 2021; 8():753056. PubMed ID: 34869560
[No Abstract] [Full Text] [Related]
85. High mobility group box protein-1 (HMGB-1) as a new diagnostic marker in patients with acute appendicitis.
Albayrak Y; Albayrak A; Celik M; Gelincik I; Demiryılmaz I; Yildirim R; Ozogul B
Scand J Trauma Resusc Emerg Med; 2011 Apr; 19():27. PubMed ID: 21507210
[TBL] [Abstract][Full Text] [Related]
86. Grade of donor liver microvesicular steatosis does not affect the postoperative outcome after liver transplantation.
Andert A; Ulmer TF; Schöning W; Kroy D; Hein M; Alizai PH; Heidenhain C; Neumann U; Schmeding M
Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):617-623. PubMed ID: 29291781
[TBL] [Abstract][Full Text] [Related]
87. Early allograft dysfunction is associated with excess resource utilization after liver transplantation.
Croome KP; Hernandez-Alejandro R; Chandok N
Transplant Proc; 2013; 45(1):259-64. PubMed ID: 23375312
[TBL] [Abstract][Full Text] [Related]
88. A nomogram for prediction of early allograft dysfunction in living donor liver transplantation.
Ko YC; Tsai HI; Lee CW; Lin JR; Lee WC; Yu HP
Medicine (Baltimore); 2020 Oct; 99(42):e22749. PubMed ID: 33080739
[TBL] [Abstract][Full Text] [Related]
89. Impact of perioperative high mobility group box chromosomal protein 1 expression on long-term outcomes in patients with esophageal squamous cell carcinoma.
Tsujimoto H; Horiguchi H; Takahata R; Ono S; Yaguchi Y; Nomura S; Ito N; Harada M; Nagata H; Ishibashi Y; Kouzu K; Tsuchiya S; Itazaki Y; Fujishima S; Kishi Y; Ueno H
J Gastroenterol Hepatol; 2020 May; 35(5):788-794. PubMed ID: 31498489
[TBL] [Abstract][Full Text] [Related]
90. Severity of early allograft dysfunction following donation after circulatory death liver transplantation: a multicentre study.
Wang K; Lu D; Liu Y; Li W; Zhuang L; Ma Z; Xie Q; Pan B; Wu Y; Chen J; Lin L; Feng X; Wei Q; Wei X; Xie H; Wang Z; Zheng S; Xu X
Hepatobiliary Surg Nutr; 2021 Jan; 10(1):9-19. PubMed ID: 33575286
[TBL] [Abstract][Full Text] [Related]
91. Perfusate Enzymes and Platelets Indicate Early Allograft Dysfunction After Transplantation of Normothermically Preserved Livers.
Weissenbacher A; Bogensperger C; Oberhuber R; Meszaros A; Gasteiger S; Ulmer H; Berchtold V; Krendl FJ; Fodor M; Messner F; Hautz T; Otarashvili G; Resch T; Margreiter C; Maglione M; Irsara C; Griesmacher A; Raynaud M; Breitkopf R; Troppmair J; Öfner D; Cardini B; Schneeberger S
Transplantation; 2022 Apr; 106(4):792-805. PubMed ID: 34144552
[TBL] [Abstract][Full Text] [Related]
92. Early Allograft Dysfunction After Live Donor Liver Transplantation: It's Time to Redefine?
Pamecha V; Pattnaik B; Sinha PK; Patil NS; Sasturkar SV; Mohapatra N; Kumar G; Choudhury A; Sarin SK
J Clin Exp Hepatol; 2022; 12(1):101-109. PubMed ID: 35068790
[TBL] [Abstract][Full Text] [Related]
93. Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.
Giovannini S; Tinelli G; Biscetti F; Straface G; Angelini F; Pitocco D; Mucci L; Landolfi R; Flex A
Cardiovasc Diabetol; 2017 Aug; 16(1):99. PubMed ID: 28789654
[TBL] [Abstract][Full Text] [Related]
94. Combination of Early Allograft Dysfunction and Protein Expression Patterns Predicts Outcome of Liver Transplantation From Donation After Cardiac Death.
Wei Q; Zhou J; Wang K; Zhang X; Chen J; Lu D; Wei X; Zheng S; Xu X
Front Med (Lausanne); 2021; 8():775212. PubMed ID: 34957150
[TBL] [Abstract][Full Text] [Related]
95. Receiving Hypertensive Donor Grafts Is Associated with Inferior Prognosis in Simultaneous Liver-Kidney Transplantation Recipients.
Zhu Z; Huang S; Zhao Q; Tang Y; Zhang Z; Wang L; Ju W; Guo Z; He X
Med Sci Monit; 2018 Apr; 24():2391-2403. PubMed ID: 29676390
[TBL] [Abstract][Full Text] [Related]
96. Interferon-γ, interleukin-10 and interferon-inducible protein 10 (CXCL10) as serum biomarkers for the early allograft dysfunction after liver transplantation.
Karakhanova S; Oweira H; Steinmeyer B; Sachsenmaier M; Jung G; Elhadedy H; Schmidt J; Hartwig W; Bazhin AV; Werner J
Transpl Immunol; 2016 Feb; 34():14-24. PubMed ID: 26658573
[TBL] [Abstract][Full Text] [Related]
97. A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction.
Satapathy SK; Gonzalez HC; Vanatta J; Dyer A; Angel W; Nouer SS; Kocak M; Kedia SK; Jiang Y; Clark I; Yadak N; Nezakagtoo N; Helmick R; Horton P; Campos L; Agbim U; Maliakkal B; Maluf D; Nair S; Halford HH; Eason JD
PLoS One; 2020; 15(5):e0232006. PubMed ID: 32407331
[TBL] [Abstract][Full Text] [Related]
98. Serum Factor V Is a Continuous Biomarker of Graft Dysfunction and a Predictor of Graft Loss After Liver Transplantation.
Gorgen A; Prediger C; Prediger JE; Chedid MF; Backes AN; de Araujo A; Grezzana-Filho TJM; Leipnitz I; Chedid AD; Alvares-da-Silva MR; Sapisochin G; Kruel CRP
Transplantation; 2019 May; 103(5):944-951. PubMed ID: 30130328
[TBL] [Abstract][Full Text] [Related]
99. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors.
Wong TC; Fung JY; Chok KS; Cheung TT; Chan AC; Sharr WW; Dai WC; Chan SC; Lo CM
Liver Transpl; 2016 Feb; 22(2):226-36. PubMed ID: 26359934
[TBL] [Abstract][Full Text] [Related]
100. Radiomic analysis of liver grafts from brain-dead donors can predict early allograft dysfunction following transplantation: a proof-of-concept study.
Robin F; Khene ZE; Livin M; Sumner C; Houssel-Debry P; Sulpice L; Boudjema K
HPB (Oxford); 2022 Sep; 24(9):1527-1534. PubMed ID: 35382981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
